Ziprasidonem indukovana galactorrhea: Kazuistika

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F05%3A00009609" target="_blank" >RIV/00216208:11120/05:00009609 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023752:_____/05:00000818

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Ziprasidone-induced galactorrhea: A case report

Popis výsledku v původním jazyce

Objectives: Second-generation antipsychotics presumably lack the typical side effects of conventional antipsychotics. Methodology: A 34 year old Caucasian woman with ICD-10 diagnosis of Recurrent depressive disorder with current moderate symptoms, and with a history of repeated self-injury was treated with lithium, clonazepam and ziprasidone. The plasma levels of prolactin were determined by the Microparticle Enzyme Immunoassay on 14th day of ziprasidone treatment and two weeks after the ziprasidone withdrawal. Results: On the ninth day of ziprasidone administration, galactorrhea appeared. After 36 days of ziprasidone therapy, galactorrhea persisted. The prolactin plasma level was 28 ng/ml. Thyroid tests and the lithium plasma level were within the normal range during ziprasidone treatment. Two weeks after the ziprasidone withdrawal, galactorrhea disappeared and the prolactin level decreased down to 18 ng/ml. Conclusion: Psychiatrists should be aware that even second-generation antipsy

Název v anglickém jazyce

Ziprasidone-induced galactorrhea: A case report

Popis výsledku anglicky

Objectives: Second-generation antipsychotics presumably lack the typical side effects of conventional antipsychotics. Methodology: A 34 year old Caucasian woman with ICD-10 diagnosis of Recurrent depressive disorder with current moderate symptoms, and with a history of repeated self-injury was treated with lithium, clonazepam and ziprasidone. The plasma levels of prolactin were determined by the Microparticle Enzyme Immunoassay on 14th day of ziprasidone treatment and two weeks after the ziprasidone withdrawal. Results: On the ninth day of ziprasidone administration, galactorrhea appeared. After 36 days of ziprasidone therapy, galactorrhea persisted. The prolactin plasma level was 28 ng/ml. Thyroid tests and the lithium plasma level were within the normal range during ziprasidone treatment. Two weeks after the ziprasidone withdrawal, galactorrhea disappeared and the prolactin level decreased down to 18 ng/ml. Conclusion: Psychiatrists should be aware that even second-generation antipsy

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FL - Psychiatrie, sexuologie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2005

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Neuroendocrinology Letters

ISSN

0172-780X

e-ISSN

—

Svazek periodika

26

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

SE - Švédské království

Počet stran výsledku

2

Strana od-do

69-70

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—